Price (delayed)
$41.15
Market cap
$821.65M
P/E Ratio
76.2
Dividend/share
$0.24
EPS
$0.54
Enterprise value
$782.95M
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.